Amicus Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. FOLD has around 25.4M shares in the U.S. ETF market. The largest ETF holder of FOLD is the SPDR S&P Biotech ETF (XBI), with approximately 6.40M shares. Investors may also find of interest that the ETF with the largest allocation to FOLD stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.13%. On average, U.S. ETFs allocate 0.34% of FOLD to their portfolios.
Additionally, FOLD is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with FOLD as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.